Cargando…
Safety of Technique and Procedure of Stromal Vascular Fraction Therapy: From Liposuction to Cell Administration
BACKGROUND: Stromal vascular fraction (SVF) therapy has been performed over the past six years to treat 421 patients by our group in five clinical centers. Autologous SVF, which is a substance containing stem cells, was isolated from lipoaspirate, mixed with platelet-rich plasma (PRP), and administe...
Autores principales: | Karina, Karina, Rosliana, Iis, Rosadi, Imam, Schwartz, Rachel, Sobariah, Siti, Afini, Irsyah, Widyastuti, Tias, Remelia, Melinda, Wahyuningsih, Komang Ardi, Pawitan, Jeanne A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362293/ https://www.ncbi.nlm.nih.gov/pubmed/32695550 http://dx.doi.org/10.1155/2020/2863624 |
Ejemplares similares
-
In vitro study of cartilage tissue engineering using human adipose-derived stem cells induced by platelet-rich plasma and cultured on silk fibroin scaffold
por: Rosadi, Imam, et al.
Publicado: (2019) -
The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study
por: Karina, Karina, et al.
Publicado: (2021) -
Corrigendum to “The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study”
por: Karina, Karina, et al.
Publicado: (2023) -
Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients
por: Karina, Karina, et al.
Publicado: (2021) -
Breakthrough in treating severe coronavirus disease 2019 (COVID-19) patients in indonesia: the use of intravenous autologous activated platelet-rich plasma
por: Karina, K., et al.
Publicado: (2021)